L&C BIO Co.,LTD (KOSDAQ:290650)
South Korea · Delayed Price · Currency is KRW 53,300
+1,500 (2.90%)
Aug 20, 2026, 3:30 PM KST
L&C BIO Co.,LTD Ratios and Metrics
Market cap in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
Total Valuation
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 19, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 1,437,485 | 1,504,212 | 546,706 | 657,862 | 524,021 | 830,267 | |
Market Cap Growth | 88.96% | 175.14% | -16.90% | 25.54% | -36.88% | 10.01% |
Enterprise Value | 1,486,720 | 1,567,319 | 613,095 | 657,447 | 594,079 | 823,218 |
Last Close Price | 53300.00 | 61100.00 | 24080.75 | 28911.57 | 22950.56 | 36285.69 |
Price Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 19, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
PE Ratio | - | - | 3.86 | 13.60 | 115.32 | 60.10 |
Forward PE | 38.56 | 32.07 | 32.07 | 37.96 | 88.62 | 80.93 |
PS Ratio | 14.65 | 17.60 | 7.59 | 9.98 | 9.97 | 18.18 |
PB Ratio | 6.74 | 7.21 | 1.88 | 4.19 | 4.86 | 8.90 |
P/TBV Ratio | 19.13 | 21.36 | 6.70 | 4.52 | 5.55 | 9.90 |
P/FCF Ratio | - | - | - | - | - | 1266.25 |
P/OCF Ratio | 74.10 | 119.72 | - | - | - | 76.13 |
EV Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 19, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
EV/Sales Ratio | 15.16 | 18.34 | 8.51 | 9.97 | 11.30 | 18.02 |
EV/EBITDA Ratio | 83.66 | 134.53 | 57.71 | 47.70 | 42.46 | 51.22 |
EV/EBIT Ratio | 158.94 | 458.86 | 158.46 | 80.87 | 62.64 | 62.51 |
EV/FCF Ratio | - | - | - | - | - | 1255.50 |
Financial Efficiency
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 19, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Debt / Equity Ratio | 0.41 | 0.44 | 0.43 | 0.52 | 0.76 | 0.07 |
Debt / EBITDA Ratio | 4.86 | 7.91 | 11.66 | 5.96 | 5.86 | 0.43 |
Debt / FCF Ratio | - | - | - | - | - | 10.42 |
Net Debt / Equity Ratio | 0.18 | 0.27 | 0.34 | 0.15 | 0.65 | -0.14 |
Net Debt / EBITDA Ratio | 2.16 | 4.75 | 9.39 | 1.66 | 4.98 | -0.80 |
Net Debt / FCF Ratio | -12.73 | -17.06 | -7.51 | -0.63 | -1.60 | -19.50 |
Asset Turnover | 0.22 | 0.18 | 0.20 | 0.28 | 0.34 | 0.49 |
Inventory Turnover | 0.99 | 0.90 | 0.78 | 0.80 | 1.10 | 1.69 |
Quick Ratio | 0.32 | 0.26 | 0.49 | 0.77 | 1.37 | 5.77 |
Current Ratio | 0.64 | 0.59 | 0.84 | 1.28 | 3.43 | 8.45 |
Return on Equity (ROE) | -53.40% | -55.36% | 64.69% | 36.92% | 5.66% | 20.17% |
Return on Assets (ROA) | 1.33% | 0.46% | 0.66% | 2.20% | 3.86% | 8.76% |
Return on Invested Capital (ROIC) | 3.72% | 1.04% | 1.36% | 3.52% | 7.35% | 18.55% |
Return on Capital Employed (ROCE) | 4.30% | 1.60% | 1.20% | 5.10% | 5.20% | 12.90% |
Yields
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 19, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Earnings Yield | -9.40% | -9.19% | 25.90% | 7.35% | 0.87% | 1.66% |
FCF Yield | -0.21% | -0.22% | -2.43% | -5.57% | -8.32% | 0.08% |
Dividend Yield | 0.09% | 0.08% | - | - | - | - |
Payout Ratio | - | - | 1.60% | 2.31% | 24.54% | 7.80% |
Buyback Yield / Dilution | -7.19% | -4.81% | 8.24% | -8.98% | -1.74% | -1.83% |
Total Shareholder Return | -7.10% | -4.73% | 8.24% | -8.98% | -1.74% | -1.83% |